Inke S.A: APIs manufacturing plant.
01 1Inke S.A
02 1Dr. Reddy\'s Laboratories
03 1Jai Radhe Sales
04 1HRV Global Life Sciences
05 1Megafine Pharma (P) Limited
06 1Shandong Loncom Pharmaceutical
07 2Alembic Pharmaceuticals Limited
08 1Amuna Pharmaceuticals
09 1Apotex Pharmachem
10 1Aurobindo Pharma Limited
11 1Beijing Fukangren Biopharmaceutical
12 1CHEMO
13 1DONG BANG FUTURE TECH & LIFE CO., LTD
14 1Enaltec Labs Private Limited
15 1Glenmark Life Sciences
16 1HEC Pharm
17 1Hetero Drugs
18 1Intas Pharmaceuticals
19 1Integrin Life Sciences
20 1Lee Pharma
21 1Lupin Ltd
22 1MSN Laboratories
23 1Macleods Pharmaceuticals Limited
24 1Optimus Pharma
25 1SGMR Pharmaceuticals
26 1SM BIOMED
27 1Saptagir Laboratories
28 1Sun Pharmaceutical Industries Limited
29 1Teva API
30 1Unichem Laboratories Limited
31 1Viatris
01 1Canada
02 3China
03 21India
04 1Israel
05 1Malaysia
06 1South Korea
07 2Spain
08 2U.S.A
01 14Active
02 1Inactive
03 17Blank
01 2Valid
02 30Blank
01 32Blank
01 1WC-0021n
02 1WC-0049
03 1WC-0057n
04 1WC-0063
05 1WC-0066
06 1WC-0067
07 1WC-0082
08 1WC-0082A12-A13
09 1WC-0087-(Annexure-1)
10 1WC-0157
11 1WC-0159
12 21Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0067
Address of the Firm :
NDC Package Code : 55111-928
Start Marketing Date : 2011-10-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Megafine Pharma is engaged in the production of APIs, and advanced intermediates, and offers contract manufacturing services.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-11-03
Pay. Date : 2015-09-14
DMF Number : 29678
Submission : 2015-08-14
Status : Active
Type : II
Date of Issue : 2022-07-27
Valid Till : 2025-07-21
Written Confirmation Number : WC-0087-(Annexure-1)
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-07-30
Pay. Date : 2013-04-09
DMF Number : 27048
Submission : 2013-06-12
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-05-21
Pay. Date : 2015-01-09
DMF Number : 28860
Submission : 2015-01-07
Status : Active
Type : II
Date of Issue : 2019-07-29
Valid Till : 2022-07-28
Written Confirmation Number : WC-0063
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-07-15
Pay. Date : 2013-04-03
DMF Number : 26925
Submission : 2013-03-25
Status : Active
Type : II
Date of Issue : 2022-06-07
Valid Till : 2025-06-25
Written Confirmation Number : WC-0057n
Address of the Firm :
NDC Package Code : 66039-887
Start Marketing Date : 2013-05-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-09-22
Pay. Date : 2013-06-18
DMF Number : 26769
Submission : 2012-12-28
Status : Active
Type : II
We have 31 companies offering DSSTox_CID_28993
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?